TITLE

Pharmacoeconomic Considerations in the Ambulatory Use of Parenteral Cephalosporins

AUTHOR(S)
Tice, A.D.
PUB. DATE
June 2000
SOURCE
Drugs;Jun2000 Supplement 3, Vol. 59 Issue 6, p29
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
It has been clearly documented that outpatient parenteral antibiotic therapy (OPAT) saves money compared with hospital care for patients who need intravenous antimicrobial therapy. The reduced expenses come primarily from savings in facility and hospital staffing costs. In addition to shortening hospital stay, OPAT programmes can be developed so that hospital care is avoided altogether. However, even with the clear potential for savings, to have a successful programme it is necessary to align the interests of the payers, the physicians, the administrators and the patients. The cost of OPAT programmes can also be reduced through patient evaluation and careful selection of the appropriate delivery model, antibiotic, dosage intervals and infusion technology. The fact that antibiotics such as ceftriaxone, the aminoglycosides and vancomycin can be given once daily in the elderly offers particular advantages in terms of convenience as well as cost. In order to achieve cost savings, managed care will increasingly rely on home and outpatient therapy. This pressure will need to be counterbalanced by quality assurance programmes and outcomes measurements.
ACCESSION #
9593664

 

Related Articles

  • Economic evaluation of antibacterials in the treatment of acute sinusitis. Laurier, C.; Lachaine, J.; Ducharme, M. // PharmacoEconomics;1999, Vol. 15 Issue 1, p97 

    Objective: The objective of this study was to compare costs, efficacy and cost efficacy of alternate oral antibacterial regimens for the ambulatory treatment of acute sinusitis. A public third-party perspective was adopted.Design: The analysis was based on a decision...

  • Cost analysis of 2 empiric antibacterial regimens containing glycopeptides for the treatment of febrile neutropenia in patients with acute leukaemia. Bucaneve, G.; Menichetti, F.; Favero, A.D.; Del Favero, A // PharmacoEconomics;1999, Vol. 15 Issue 1, p85 

    Objective: Patients with cancer-associated neutropenia are at high risk of developing severe infections which can be fatal if treatment is not promptly administered. For this reason, fever is treated as soon as possible with broad spectrum antibacterial therapy. The objective of...

  • Procalcitonin assay reduces antibacterial use in LRTIs.  // PharmacoEconomics & Outcomes News;2/28/2004, Issue 447, p5 

    Provides information on a study regarding the reduction of antibacterial use in patients with suspected lower respiratory tract infections (LRTI) through a procalcitonin-based therapeutic strategy. Analysis of the capability of a procalcitonin assay to identify bacterial LRTI requiring...

  • The Burden of Prostatitis in the United States. McNaughton-Collins, Mary; Pontari, Michel // AUANews;May2007, Vol. 12 Issue 5, p2 

    The article discusses a study which quantified the burden of prostatitis in the U.S. by identifying trends in the use of health care resources and estimating the economic impact of the disease. It is stated that the cost of prostatitis is estimated at $84 million per year, exclusive of...

  • Antibacterial drug formulary proves valuable in Slovenia.  // PharmacoEconomics & Outcomes News;2/12/2005, Issue 471, p12 

    Discusses research being done on the evaluation of the introduction of an antibacterial drug formulary at the Celje General Hospital in Slovenia. Reference to a study by J. Peklar and colleagues, published in the December 2004 issue of the "Pharmacy World and Science"; Timeframe of the analysis...

  • Higher hospital costs and lengths of stay associated with quinolone-resistant Salmonella enterica infections in Hong Kong. Broughton, Edward I.; Ip, Margaret; Coles, Christian L.; Walker, Damian G. // Journal of Public Health;Jun2010, Vol. 32 Issue 2, p165 

    Objectives: The study sought to determine the differences in lengths of stay and medical costs between patients admitted to hospital with non-typhoidal salmonellosis that were either quinolone resistant (QR) or quinolone susceptible (QS).

  • Threshold Analysis of Helicobacter pylori Therapy. Sonnenberg, A. // PharmacoEconomics;1998, Vol. 14, p423 

    Objective: Conflicting recommendations have been made on whom to treat with antibacterials to eradicate Helicobacter pylori. The present analysis aims to explain the basis of such discrepancies. Design and Setting: The decision in favour of or against antibacterial therapy in patients with upper...

  • Vancomycin-Resistant Enterococci Outbreak, Germany, and Calculation of Outbreak Start. Sagel, Ulrich; Schulte, Berit; Heeg, Peter; Borgmann, Stefan // Emerging Infectious Diseases;Feb2008, Vol. 14 Issue 2, p317 

    On the basis of a large outbreak of vancomycin-resistant Enterococcus faecium in a German university hospital, we estimated costs (≈1 million Euros) that could have been avoided by early detection of the imminent outbreak. For this purpose, we demonstrate an easy-to-use statistical method.

  • Intervention programme curbs antibacterial use and costs in Thailand.  // PharmacoEconomics & Outcomes News;4/22/2006, Issue 501, p6 

    Reports on a study which showed that a multifaceted intervention program can improve antibacterial prescribing practices, reduce the rates of antibacterial use and bacterial resistance, and reduce associated costs within one year. Components of the intervention program; Total cost savings from...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics